Parameter (Units) Linezolid 600 mg tablet (Reference treatment) N=20 Linezolid 600 mg oral suspension (Test treatment) N=20
AUCinf (µg*h/mL), mean (± SD)* 112.6 (24.9) 109.2 (21.7)
AUClast (µg*h/mL), mean (± SD)* 112.0 (24.7) 108.9 (21.7)
Cmax (µg/mL), mean (± SD)* 13.7 (3.5) 15.5 (3.5)
Tmax (h), median (range) 1.50 (0.5–4.0) 0.63 (0.5–2.0)
t1/2 (h), mean (± SD)* 5.13 (0.92) 5.08 (0.70)
AUCinf, area under plasma concentration–time curve from time zero extrapolated to infinite time; AUClast, area under plasma concentration–time curve from time zero to the time of the last quantifiable concentration; Cmax, maximum plasma concentration; SD: Standard Deviation; t1/2, elimination half-life; Tmax, time for maximum plasma concentration. *Arithmetic mean.
Table 1: Descriptive summary of pharmacokinetic parameters of plasma linezolid following single oral doses of 600 mg oral suspension and 600 mg tablet formulations in healthy Chinese subjects.
Goto home»